Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 5Unknown 2Terminated 2Recruiting 2Withdrawn 1Not yet recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Colorectal Neoplasms 13Head and Neck Neoplasms 9Squamous Cell Carcinoma of Head and Neck 5Neoplasm Metastasis 3Lung Neoplasms 3Carcinoma, Squamous Cell 3Carcinoma, Non-Small-Cell Lung 3Recurrence 2Pancreatic Neoplasms 2Neoplasms 2Esophageal Neoplasms 2Colonic Neoplasms 2Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Triple Negative Breast Neoplasms 1Stomach Neoplasms 1Sarcoma 1Rectal Neoplasms 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Ovarian Neoplasms 1Oropharyngeal Neoplasms 1Neoplastic Cells, Circulating 1Neoplasms, Squamous Cell 1Laryngeal Diseases 1Hereditary Sensory and Autonomic Neuropathies 1Endometrial Neoplasms 1Chordoma 1Carcinoma 1Breast Neoplasms 1Advanced Cancers 1

Interventions

Cisplatin 3X-Rays 2zimberelimab 1durvalumab 1dl1520 1cemiplimab 1balstilimab 1Taxes 1Standard of Care 1Radiation 1Practice Guidelines as Topic 1Polymerase Chain Reaction 1Narrow Band Imaging 1Magnetic Resonance Spectroscopy 1MEDI0457 1Lansoprazole 1Gene Expression Profiling 1Gabapentin 1Fluorouracil 1Fluorodeoxyglucose F18 1Exercise Test 1Drug Delivery Systems 1Dexlansoprazole 1Cetuximab 1Blood Specimen Collection 1Alpelisib 1Absorptiometry, Photon 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Withdrawn × Oropharyngeal Neoplasms × Cetuximab × Clear all
NCT02298595 2017-11-13

Cetuximab, Cisplatin and BYL719 for HPV-Associated Oropharyngeal Squamous Cell Carcinoma

University of Pittsburgh

Phase 1/2 Withdrawn
Head & Neck

Carcinoma, Carcinoma, Squamous Cell, Oropharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡